New sedative may shield heart during lung surgery
NCT ID NCT07028593
First seen Feb 01, 2026 · Last updated May 08, 2026 · Updated 7 times
Summary
This study tests whether a newer sedative called ciprofol can reduce heart damage after lung surgery compared to the standard drug propofol. About 1,058 adults aged 45–80 having keyhole lung surgery will be randomly assigned to receive one of the two drugs. The main goal is to see if ciprofol lowers the rate of heart injury in the days after surgery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYOCARDIAL INJURY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Tongji hospital
RECRUITINGWuhan, China
Contact
Contact
Conditions
Explore the condition pages connected to this study.